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High-fat diet-induced obesity and 
insulin resistance are characterized 
by differential beta oscillatory 
signaling of the limbic cortico-basal 
ganglia loop
Lukas Maurer1,2,3,5, Hui Tang1,2,3, Jens K. Haumesser4, Jennifer Altschüler4, Andrea A. Kühn4, 
Joachim Spranger1,2,3 & Christoph van Riesen4
The concept of brain circuit disorders has been proposed for a variety of neuropsychiatric diseases, 
characterized by pathological disturbances of neuronal networks including changes in oscillatory 
signaling of re-entrant cortico-subcortical loops in the basal ganglia system. Parts of this circuitry 
play a pivotal role in energy homeostasis. We therefore investigated whether high-fat diet (HFD) 
induced obesity is associated with changes in oscillatory signaling in the limbic cortico-basal ganglia 
loop. We performed multi-site in-vivo electrophysiological recordings of local field potentials within 
this network under urethane anesthesia in adult rats after 4 weeks of HFD feeding compared to age-
matched controls. Recordings were performed at baseline and during systemic glucose challenge. Our 
analysis demonstrates increased oscillatory beta power in the nucleus accumbens (NAC) associated 
with decreased beta coherence between cortex and NAC in animals fed a HFD. Spontaneous beta 
oscillatory power strongly correlated with endocrine markers of obesity. The glucose challenge 
increased beta oscillations in control animals but not in animals receiving the HFD. Furthermore direct 
intracerebroventricular insulin injection increased beta oscillations in the NAC. The present study 
provides evidence for aberrant oscillatory signaling in the limbic cortico-basal ganglia loop that might 
contribute to the dysfunctional information processing in obesity.
The prevalence of obesity and type 2 diabetes (T2DM) has reached epidemic proportions worldwide1. Primarily 
reward related overconsumption of highly palatable, energy dense foods beyond homeostatic needs is consid-
ered a central aspect in the multifactorial pathogenesis of obesity and its accompanying metabolic distortions2. 
Dysfunctional information flow of cortico-striatal networks involved in metabolic regulation as well as reward 
processing has been suggested to be of importance for the pathophysiology of obesity3,4. The limbic cortico-basal 
ganglia loop plays a central role in the brains reward circuitry that is responsible for the processing of reward 
related aspects of food consumption and it is intricately interconnected with hypothalamic midbrain areas that 
regulate the organism’s homeostatic functions5. In addition, peripheral hormones like insulin, leptin and ghre-
lin have been shown to modulate neuronal function within the basal ganglia6. In the context of obesity, multi-
ple functional brain imaging studies have demonstrated cortical and striatal areas show profound differences 
between lean and obese individuals7,8. In obese participants an enhanced activation during food anticipation 
accompanied by a decreased activation during food reward receipt was reported9. It has been hypothesized that 
a central aspect of obesity might be an altered reward processing in the cortico-basal ganglia network similar 
to what has been found in models of addiction10. Thus, the controversial concept of obesity being a disorder 
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based on food addiction has been postulated11. In line with this, obesity could be regarded as another neuropsy-
chiatric brain circuit disorder similar to addiction, obsessive-compulsive disorder or Parkinson’s disease, which 
is supported by recent progress in the molecular and optogenetic dissection of the neurocircuitry involved in 
the regulation of food intake and metabolism12. The etiologies of circuit dysfunction are multivarious including 
damage of specific neuronal pathways, loss of individual neuronal populations and aberrant functional activity 
characterized by pathological oscillatory activity13. While a number of these aspects like impaired dopaminergic 
neurotransmission14 or neuronal injury due to hypothalamic inflammation15 have been addressed in the context 
of obesity, the question of whether aberrant network activity occurs in the involved neuronal circuits has not 
been clarified. To address this important question we aimed to characterize information processing in the limbic 
cortico-basal ganglia loop by simultaneous multi-site local field potential (LFP) recordings. LFPs are extracellular 
signals that are primarily generated by the summed activity of excitatory and inhibitory synaptic potentials within 
groups of neurons16. Due to their biophysical properties LFPs pose an opportunity to characterize the coordi-
nation of neuronal population activity within a defined network16. Recent cumulative evidence suggests that 
oscillations are of paramount importance for interneuronal communication in small- and large-scale neuronal 
networks17,18 with oscillations at different frequencies subserving different functions17. Furthermore the coher-
ence of oscillatory signals between different brain areas has been proposed as a marker of functional connectivity 
that regulates neuronal communication through selective synchronization of neuronal populations19. The term 
oscillatory signaling as it is used here refers to the general description of the power and coherence of oscillatory 
LFPs within and between specific neuronal target areas. Recent studies on human patients suffering from debili-
tating neuropsychiatric diseases such as Parkinson´s disease, obsessive-compulsive disorder and depression have 
demonstrated a close relation between altered oscillations at specific frequencies and disease symptoms, suggest-
ing a causal relation20–22. In the current study, we performed parallel in vivo-electrophysiological recordings of 
LFPs under urethane anesthesia from the medial prefrontal cortex (mPFC), nucleus accumbens (NAC) and the 
ventral tegmental area (VTA) at baseline and during a standardized intraperitoneal glucose tolerance test. We 
demonstrate that HFD induced obesity is characterized by an increase of beta oscillatory power in the limbic 
cortico-basal ganglia loop that is most pronounced in the NAC and accompanied by a decreased coherence in 
the beta frequency band between the NAC and the mPFC. NAC beta activity is highly correlated to diet-induced 
elevations of insulin and leptin levels at baseline while showing a differential group-dependent response towards 
a systemic glucose challenge.
Material and Methods
Animal model. In total 75 male wistar rats (RccHanWist, Harlan Laboratories, Netherlands) aged 14–16 
weeks were used for this experiment. Rats were housed in a temperature- and humidity-controlled environment 
with 12-h light dark cycle with food and water available ad libitum. Rats were housed in groups of up to 4 animals. 
We opted for group housing, because a lower response for diet induced obesity has been shown for single housed 
animals23. In the first experimental set 45 rats were divided in two groups (control group N = 15, HFD group 
N = 30) and fed over a period of four weeks. There were no significant weight differences between the groups 
before the start of the experiments. Animals were randomly assigned to the groups. The control group received a 
standard lab chow diet (TD.2014, Harlan Laboratories, Netherlands). 45 animals were fed a high fat diet (HFD) 
with 45% kcal from fat (TD08811, Harlan Laboratories, Netherlands) for two weeks. All animals were ranked 
according to their body weight. The 15 animals with the lowest and highest body weight gain after the first two 
weeks were selected (mean body weight 374 vs. 340 g), further subclassified as HFD high response (HFD-H, 
N = 15) or HFD low response group (HFD-L, N = 15) and fed for two additional weeks. The initial intent was 
to select two metabolically distinct groups as it has been described before24. In our experiment, we could not 
replicate this phenotype after four weeks of HFD feeding. As shown in the Supplementary Material (Table S1, 
Figure S2) we have a rather broad distribution with respect to the extent of the metabolic phenotype. We therefore 
did not sub specify the groups for the further analysis. In the first cohort, 13 of 45 animals were excluded from 
final analysis (Control N = 12, HFD N = 20) for the following reasons: no AS detectable (N = 5), death during 
procedure (N = 4), incorrect glucose injection (N = 2), electrode malfunction (N = 1), no sufficient blood sam-
pling (N = 1). In a second cohort 30 male wistar rats aged 14–16 weeks received an intracerebroventricular insulin 
(N = 15) or saline (N = 15) injection. In this cohort, we excluded 7 of 30 animals from the final analysis (insulin 
N = 12, saline N = 11) for the following reasons: death during procedure (N = 3), no AS detectable (N = 3), elec-
trode malfunction (N = 1).The study was conducted in accordance with German Animal Welfare Act (last revised 
in 2014) and European regulations (2013/63/EU). All experiments were approved in advance by the local animal 
welfare authority (LaGeSo, Berlin) and conformed to local department and international guidelines.
In vivo electrophysiology. In vivo electrophysiological recordings were made as previously described25. In 
brief, anesthesia was induced and maintained with urethane (1.3 g/kg i.p., Sigma–Aldrich, Germany). Rats were 
placed in a stereotactic frame (David Kopf Instruments, CA, USA) with heads fixed with atraumatic ear bars. 
Ophthalmic ointment (Bepanthen™, Bayer, Germany) was applied to prevent corneal dehydration. Body tem-
perature of 37 ± 0.5 °C was maintained throughout surgery using a self-adjusting heating pad (CMA, Sweden). 
After incision of the skin, the head was aligned to the flat skull position using the rat alignment tool (David Kopf 
Instruments, CA, USA). Three customized parylene insulated tungsten electrodes (Microprobes, USA, tip diam-
eter 4 µm, impedance 1MOhm) were implanted unilaterally into the left medial prefrontal cortex (AP = +3.2, 
ML = +0.7, DV = −4.0), nucleus accumbens shell (AP = +1.8, ML = +0.7, DV = −7.0) and the ventral tegmen-
tal area (AP = −5.0, ML = +0.7, DV = −8.3). All coordinates are given in mm in reference to Bregma26. All elec-
trodes were secured with acrylic dental cement (Technovit®, Heraeus-Kulzer, Germany). Animals and implanted 
electrodes were left fixed to the stereotactic frame throughout the experiment. Recording electrodes were refer-
enced against a custom-made Ag-AgCl electrode that was positioned in the epidural space above the ipislateral 
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cerebellum. Signals were bandpass filtered (0.05 Hz–300 Hz), amplified, sampled at 1 kHz and digitized using a 
programmable neuronal data acquisition system (Omniplex, Plexon, Texas, USA) and stored for later offline data 
analysis.
Data analysis. LFP recording under urethane-anesthesia was used as a well-established model for investigat-
ing basal ganglia activity and functional connectivity of the cortico-striatal system27,28. We focused our analysis 
on activated states (AS) that are characterized by fast, low amplitude signals that have been found to resemble 
oscillatory activity in the awake state independent of movement artifacts and motivational states27,29,30. 50-second 
periods of an AS was selected visually as described previously25,31 (for more detailed description and represent-
ative depiction of the raw signal see supplementary material). The same time segments were also used for anal-
ysis of LFPs from the NAC and the VTA. Power spectral densities of the LFP data segments were calculated 
by employing the Fast Fourier Transform function. The frequency spectrum was divided into standard EEG 
bands32. Power spectra were normalized to total power between 7 and 100 Hz and further expressed in arbitrary 
units (a.u.). Peak oscillatory activity was determined by selecting the peak frequency bin with the highest power 
value compared to its preceding frequency bin within the 13–20 Hz frame of the low beta frequency band. NAC 
beta peak frequency power was calculated as mean power of this and the two adjacent frequency bins. Averaged 
power across the specific frequency bands was used for statistical comparisons. To measure functional connec-
tivity between the three different target areas we performed a coherence analysis33. Coherency is defined as the 
normalized cross-spectrum. Coherence is defined as the absolute value of coherency reflecting the linear rela-
tionship between the phase consistency of two signals at a specific frequency34. To exclude volume conduction as 
a confounder we focused on the calculation of the imaginary part of coherence (iCoherence; out of phase part of 
coherence34. For the coherence analysis the same time fragments as for the power spectrum density calculations 
were used35. In the first cohort, three separate time frames were analyzed: one during baseline recording and two 
during the performance of the i.p. glucose tolerance test (one and two hours after the glucose injection). In the 
second cohort, two time frames one before and one after intracerebroventricular injection of insulin or saline 
were analyzed. Correct electrode tip placements were histologically verified using sections stained with standard 
Nissl (for further description of data analysis and histology protocols see supplementary material).
i.p. Glucose tolerance test, i.c.v. insulin injection and hormone measurements. Standard i.p. 
glucose tolerance testing was performed using a 20% glucose solution in a weight-adjusted dosage (2 mg/g body 
weight). The procedure started 7–8 hours after food removal and initiating of the anesthesia. Whole tail blood sam-
pling was performed at 0, 30, 60, 90 and 120 minutes. Glucose levels were measured using a standard measurement 
devise (Contour XT, Bayer, Germany). Insulin and leptin measurements were performed using commercially avail-
able ELISA kits (10-1247-01, Mercodia, Sweden, Cat.Nr. MOB00, R&D Systems, USA). For further information, see 
supplementary material. The intracerebroventricular insulin injection was performed using a 33-gauge blunt-tip 
cannula fixed on a 10 μl Hamilton syringe (WorldPrecision Instruments, FL, USA). The third ventricle was targeted 
using the stereotactic coordinates AP: −2.3, ML: 0.0, DV: −8.5 mm. 2 μl of 4mU/l insulin or saline was injected at a 
pace of 1 μl/min via a precision syringe pump (Micro4™, World Precision Instruments, FL, USA).
Data availability statement. The datasets generated during and analyzed during the current study are 
available from the corresponding author on reasonable request.
Statistics. Statistical calculations were performed using SPSS 20.0 (IBM Statistics, Germany). All values 
are presented as mean and standard error of the mean (SEM). Metabolic parameters were log transformed. 
Normal distribution was tested using Shapiro Wilk test. Normally distributed metabolic parameters and elec-
trophysiological data were analyzed using student’s t-test. Skewed variables (body weight) were analyzed using 
Mann-Whitney-U-test. For subgroup analysis one-way ANOVA and Kruskall-Wallis test were used accordingly. 
Bonferroni correction was applied to adjust for multiple comparisons. To test for a group time interaction a 
split-plot repeated measures ANOVA was performed. Repeated-measures ANOVA was used to analyze differ-
ences in beta activity between the different metabolic conditions. Correlations were calculated by Spearman’s rank 
correlation coefficient. We used a linear regression model to adjust for cortical slow wave activity, time point of 
sampling and body weight for evaluating associations between oscillatory activity and insulin levels. The signifi-
cance level was chosen as p < 0.05.
Results
Metabolic baseline characteristics. In the main cohort, rats were randomly assigned to receive either a 
normal chow (controls) or a high fat diet (HFD) for a period of 4 weeks. The HFD group reached a significantly 
higher body weight than the age-matched control animals (Table 1). Baseline glucose values showed no signifi-
cant difference between the two groups (Table 1). The standard i.p. glucose tolerance test (GTT) was conducted 
during the electrophysiological recordings under urethane anesthesia revealing a significantly higher area under 
the curve (AUC) glucose level for the HFD group compared to controls. In accordance, insulin levels at baseline 
as well as the insulin AUC were higher in HFD animals (Table 1). Basal serum leptin concentrations were more 
than doubled in the HFD group compared to controls (Table 1). The time course of glucose and insulin levels 
during the i.p. GTT are presented in the supplementary material (Figure S2). Of note are the overall increased 
serum concentrations and rather constant elevation over the 2-hour test duration that are known to manifest 
under general anesthesia with urethane.
The further analysis of the sub classification within the HFD group based on a rather high versus low initial 
weight gain under high fat diet exposure (HFD-H vs. HFD-L) revealed no significant differences between the sub-
groups with respect to body weight, glucose and leptin concentrations. Solely insulin concentrations and insulin 
AUC separated these two subgroups (Supplementary Material Table S1). The metabolic characterization indicated a 
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distinct between group difference for animals receiving normal chow versus receiving a high fat diet. The metabolic 
phenotype within the HFD group on the other hand displays a rather continuous spread (Supplementary Material 
Figure S2). We therefore focused for the primary analysis on the comparison between animals receiving either con-
trol chow or a high fat diet. In the first cohort, 32 of the 45 animals were included in the analysis. 13 animals were 
excluded for the following reasons: Control group - no AS detectable (N = 1), no raise in glucose levels presumably 
due to incorrect glucose injection (N = 2); HFD-H group - no AS detectable (N = 2), no sufficient blood sampling 
(N = 1), death during procedure (N = 2); HFD-L group - no AS detectable (N = 2), electrode malfunction (N = 1), 
death during procedure (N = 2). In the second cohort for the icv insulin injection we included 23 of 30 animals. 
Three animals died during the procedure. In one case the electrode in the nucleus accumbens did not record prop-
erly. Three animals had to be excluded since no activated state could be detected.
HFD group showed increased beta power in the cortico-basal ganglia loop at baseline. We 
performed simultaneous local field potential recordings from the mPFC, the VTA, and the NAC in all animals. 
Epochs of robust global cortical activation (activated states) were analyzed at baseline and during the first and 
second half of the glucose tolerance test. To exclude that urethane might have had a different effect on cortical 
synchronization states in animals with diverse body compositions we compared the power of low frequency oscil-
lations (<1 Hz) of the chosen activated states between the different experimental groups. As urethane anesthesia 
is dominated by oscillations at this frequency band, a difference in anesthesia depth or of the frequency content 
of the activated states would be detectable by this analysis. We could not find any significant differences in this 
measurement (Table 2). The only definite frequency peak over the investigated frequency spectrum was identified 
in the low beta frequency band (13–20 Hz) in recordings from the NAC with a concordant but less pronounced 
effect in VTA and mPFC (Fig. 1). Calculation of the mean power of the frequency band revealed a significant 
increase in low beta power in animals fed a HFD (Table 2).
HFD group showed a selective decrease of cortico-subcortical coherence in the beta frequency 
band at baseline. To analyze the functional connectivity within the limbic loop of the cortex-basal gan-
glia network we analyzed iCoherency between the recorded cortical and subcortical targets (Fig. 2). At baseline 
Control HFD
Body Weight [g] 401.1 (3.5) 457.7 (11.9)**
Baseline Glucose [mg/dl] 132.7 (8.3) 157.6 (8.4)
AUC Glucose [a.u.] 29065.0 (2388.3) 36414.8 (1940.1)*
Baseline Insulin [µg/l] 3.7 (0.4) 8.3(0.6)**
AUC Insulin [a.u.] 663.0 (47.1) 1391.3 (90.2)**
Leptin [ng/ml] 11.0 (2.44) 25.0 (2.7)*
Table 1. Baseline metabolic characteristics of the groups: values are depicted as mean value (S.E.M.) for 
normal chow group (Control N = 12), high fat diet group (HFD N = 20). T-test was used to compare metabolic 
parameters, *p < 0.05, **p < 0.001.
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Table 2. Statistical analysis of mean power and iCoherence of the low beta frequency band under baseline 
condition. Cortical slow wave activity (mPFC SlowWave 0–1 Hz) was analyzed as control parameter for a 
potential overall influence of anesthesia. Visually identified between group difference (Control N = 12, HFD 
N = 20) in PSD and iCoherence was analyzed using student’s t-test.
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iCoherence values calculated for the combination of mPFC and the NAC as well as for the mPFC and the VTA 
showed a significantly lower mean coherence in the low beta frequency band in animals fed with a high fat diet 
(Table 2). No consistent difference was detected for the iCoherence between VTA and NAC.
In hyperglycemia beta oscillations increased and beta coherence decreased in control animals 
while remaining stable in the HFD group. After the completion of the baseline recordings we proceeded 
with LFP recordings after an i.p. injection of 2 mg/g body weight of glucose. Power spectral densities were cal-
culated after the first and the second hour following the injection (Fig. 1). The power analysis of the first time 
segment showed a significantly increased low beta power in control animals (Figs 1 and 3), that was most pro-
nounced in the NAC. In the high fat diet group, low beta power remained on the elevated level observed before 
the glucose challenge (Fig. 3). This effect remained stable for the second time point. Repeated-measure ANOVA 
analysis revealed a significant time group interaction (Tests of Within-Subjects Contrasts, Mean Square 3.91, 
p < 0.001) for the comparison of NAC beta activity in the three measured AS timeframes. Beta power levels 
were not statistically different between control and HFD-animals in hyperglycemia at both time points (Fig. 3). 
Beta coherence between NAC and mPFC displayed a similar pattern with opposite direction (Fig. 2). The ini-
tially higher beta coherence in control animals was significantly reduced after glucose application while similar 
modulation in the HFD group (time group interaction - Tests of Within-Subjects Contrasts, Mean Square 0.32, 
p = 0.007).
NAC beta oscillatory power correlated with metabolic markers at baseline. To further evaluate 
possible interactions between oscillatory phenomena in the limbic cortico-striatal system and the metabolic pro-
file in general, we analyzed correlations of baseline NAC mean beta activity (13–20 Hz) and NAC beta peak fre-
quency power with the recorded metabolic markers of the whole animal cohort independent of group assignment 
(Supplementary Material Table S2). Bivariate correlation analysis revealed strong positive associations between 
NAC beta peak power with body weight (r = 0.49, p = 0.004), glucose AUC (r = 0.46, p = 0.008) and serum leptin 
levels (r = 0.49, p = 0.005; scatter plots provided in Supplementary Material Figure S3). The strongest positive 
correlation consisted between NAC beta peak power and baseline insulin levels (Fig. 4). In the linear regres-
sion analysis this association (adj. r² = 0.44, ß = 0.68, p < 0.001) persisted even when correcting the model for 
slow wave activity, measurement time point and the animal’s body weight (adj. r² = 0.39, ß = 0.59, p < 0.013). 
Figure 1. Power Spectral Density (PSD) analysis over a frequency spectrum from 7 to 45 Hz depicted as 
mean arbitrary unit [A.U.] for 1 Hz frequency bins ± SEM. Row one: medial prefrontal cortex (mPFC), row 
two: nucleus accumbens shell region (NAC) and row three: ventral tegmentum area (VTA). The left column 
shows PSD data for the baseline condition, measured before the initiation of the glucose tolerance test (Control 
N = 12, HFD N = 20). The middle column shows PSD data measured during the first hour of the glucose 
tolerance test (Control N = 11, HFD N = 18) and the right column during the second hour of the test (Control 
N = 11, HFD N = 18). Grey area marks the low beta frequency spectrum (13–20 Hz).
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Analysis of the relationship between NAC beta peak power and baseline insulin within the two experimental 
groups revealed a significant association within the HFD group (r = 0.47, p = 0.037) but not in control animals 
(r = 0.16, p = 0.65). This association was specific only for NAC beta power. It was not detected in mPFC and VTA 
nor did beta coherence correlate with markers of the metabolic phenotype. The baseline association of insulin 
and NAC beta peak power disappeared after i.p. glucose application and was not detected anymore during the 
glucose tolerance test (Fig. 4).
ICV insulin injection increases NAC beta oscillatory power. To investigate if the observed increase in 
beta oscillatory activity in the NAC was resulting from central insulin signaling, we performed an additional set of 
experiments in lean control animals. Mean beta oscillatory power in the low beta frequency band of the NAC was 
measured before and after central insulin injection (Fig. 5). ICV insulin application induced a significant increase 
in mean NAC beta power (pre injection 3.03 [a.u.], post injection 3.64 [a.u.], p = 0.031) while sham injection 
induced no change (pre injection 3.10, post injection 2.87, p = 0.279). Of note the induced beta peak had as maxi-
mum around at 19–20 Hz, while the observed beta peak after systemic glucose application spiked at around 15 Hz. 
There were no significant between group differences with respect to body weight (insulin group 387.1 g vs. sham 
group 384.9 g) and time between AS and insulin application (pre injection: insulin group −21.0 min vs. sham 
group −19.5 min, p = 0.883; post injection: insulin group +33.4 min vs. sham group post injection +42.8 min, 
p = 0.303).
Discussion
In the current study we followed a systematic combined approach of endocrinological testing and characteriza-
tion of the neuronal network activity in a rat model of obesity. Based on the idea of a circuit disorder with abnor-
mal reward processing in diet induced obesity we explored oscillatory LFP activity within the limbic circuit of the 
cortico-basal ganglia loop before and during a systemic glucose challenge. Our main findings are: 1.) A distinct 
peak in the low beta frequency band was found in the nucleus accumbens of the animals that received a high fat 
diet for 4 weeks. 2.) Beta power correlated with body weight and serum leptin as well as insulin levels at baseline 
pointing to an association between central beta activity and peripheral metabolic parameters. 3.) Beta power 
increased in controls during a defined i.p.-glucose challenge but no further increase occurred in animals pre-
treated with a high fat diet. 4.) Cortico-subcortical beta band coherence between the mPFC and the NAC as well 
as the mPFC and the VTA was reduced in the HFD groups and was differentially modulated after the systemic 
Figure 2. iCoherence analysis over a frequency spectrum from 7 to 45 Hz depicted as mean coherence for 
1 Hz frequency bins ± SEM. Row one: medial prefrontal cortex (mPFC) with nucleus accumbens shell region 
(NAC), row two: medial prefrontal cortex (mPFC) with ventral tegmentum area (VTA) and row three: nucleus 
accumbens shell region (NAC) with ventral tegmentum area (VTA). The left column shows PSD data for the 
baseline condition, measured before the initiation of the glucose tolerance test (Control N = 12, HFD N = 20). 
The middle column shows PSD data measured during the first hour of the glucose tolerance test (Control 
N = 11, HFD N = 18) and the right column during the second hour of the test (Control N = 11, HFD N = 18). 
Grey area marks the low beta frequency spectrum from 13 to 20 Hz.
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glucose application. Oscillatory brain activity has only rarely been studied in the context of obesity. In a magneto-
encephalographic (MEG) study with obese and lean humans it could be demonstrated that cortical beta activity 
can be increased by insulin in lean subjects but not in obese patients36. This study is partly in line with what we 
could show in our data set and underscores the hypothesis that insulin might play an important role in the context 
of hormonal and possibly disease related modulation of brain rhythms. In a recent EEG study elevated cortical 
beta activity was identified in overweight women depicting a linear relationship between relative beta band power 
and body fat mass37. While MEG/EEG-based approaches are limited to the analysis of cortical activity, invasive 
recording approaches allow the assessment of subcortical components of the cortico-striatal system. Utilizing this 
invasive approach gamma oscillations have been identified to organize top-down signaling to the hypothalamus 
enabling food seeking behavior in mice38.
Our data show a more pronounced alteration of oscillatory activity in the NAC compared to mPFC suggesting 
a pivotal role of subcortical areas for the generation of oscillatory signaling. Based on the well investigated role 
of insulin as a brain satiety signal39 interfering with dopaminergic neurotransmission40,41 and the discovery of 
exaggerated beta oscillatory activity in the dopamine depleted basal ganglia system of parkinsonian patients20, 
it is tempting to formulate the hypothesis that beta oscillatory activity and coherence in obesity might constitute 
a relevant modality of reward regulation through central insulin signaling. To investigate the potential role of 
brain insulin signaling in this context, we performed an additional set of experiments evaluating the change of 
NAC beta oscillatory power following a direct insulin injection in the third ventricle. This approach of delivering 
Figure 3. Mean low beta power and low beta-iCoherence (13–20 Hz) ± SEM for the three measured AS 
conditions: Baseline (Control N = 12, HFD N = 20), 1st (Control N = 11, HFD N = 18) and 2nd (Control N = 11, 
HFD N = 18) time segment after i.p.-glucose injection. Graphs depict the three targeted areas medial prefrontal 
cortex (mPFC), nucleus accumbens (NAC) and ventral tegmentum area (VTA). Paired t-test was used for post-
hoc testing to analyze differences in beta activity between the conditions, *p < 0.05.
Figure 4. Correlation of NAC beta peak power and insulin levels measured before (N = 31) and during the first 
(N = 29) and second half (N = 29) of the glucose tolerance test.
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insulin directly into the brain has been used in a number of animal studies to explore central insulin action as 
a satiety signal in discrimination to its glucose lowering effect in the periphery39. While the potential of brain 
insulin signaling to lower food intake is well established, in a recent animal study it has been demonstrated that 
the action of appetite suppressant drugs is mediated by dopaminergic signaling and associated with changes in 
beta, theta and delta band LFP oscillations42. The results of our experiments show that central insulin application 
induced an increase in NAC beta oscillations. The frequency peaks of this increased beta oscillatory activity vary 
between systemic glucose and i.c.v. insulin application, potentially indication that insulin is relevant but not the 
only factor mediating this effect. Since we are at this point unable to address the question of what increased beta 
oscillatory signaling means for neuronal computation in obesity, it is interesting to consider what is known from 
other contexts. Data from animal and human studies in various fields led to the formulation of the hypothesis 
that beta band activity has a primary role in health and disease. On the one hand, under physiological conditions 
beta oscillations seem to promote the maintenance of the current sensorimotor or cognitive state43. On the other 
hand increased beta activity is associated with a pathological persistence of the current sensorimotor state, which 
might directly result in the disease symptoms in PD that are characterized by a lack of movement and problems in 
initiating movements20. Since these investigations on oscillatory activity have given rise to a number of promising 
novel neuromodulatory approaches like closed-loop deep brain stimulation44 or patterned transcranial stimula-
tion45, a further characterization of oscillatory network activity could help to facilitate the development of novel 
therapies for obesity. In fact preclinical and clinical studies on DBS in obesity have brought first evidence that this 
therapy might be effective46.
Our experimental design comes with a number of relevant limitations. A drawback is that we have con-
ducted our experiments under general anesthesia with urethane. Urethane like almost all general anesthetics 
has been described to have an impact on various hormone levels especially with respect to the glucose metab-
olism. Systemic administration of urethane leads to a sympathetic response with release of insulin antagonistic 
hormones inducing a raise of glucose values and an attenuation of insulin’s capacity to lower serum glucose 
levels47,48. These effects can clearly be recognized in the metabolic characterization of the animals investigated in 
our experiment (Table 1). While the rather constant increase in blood glucose and insulin levels after the systemic 
challenge facilitates the analysis of oscillatory activity with respect to metabolic parameter, it exemplifies the 
non-physiologic condition of the used approach. Nevertheless, the relative differences between the groups match 
the expected metabolic changes following a 4 week high fat diet feeding in terms of an up to 20% increase in body 
weight, accompanied by an impaired glucose tolerance in the GTT as measured by AUC glucose and insulin levels 
without manifestation of a different baseline glucose level. Despite that, the usage of urethane anesthesia has a 
number of essential advantages for testing the hypothesis of a potential neuro-endocrine interaction. It produces 
a stable and long lasting anesthesia that allows performing electrophysiological experiments for hours29. It is 
therefore possible to record and analyze signals that are not compromised by sensory stimuli (e.g. pain and stress 
during blood sampling) and specific behaviors with respect to metabolic alterations. The two very well defined 
cortical activation states - slow wave activity (SWA) and activated state (AS) - occur spontaneously under ure-
thane anesthesia. While the SWA state resembles cortical activity during natural sleep, the AS shows many char-
acteristics of brain activity patterns that can be found in awake and attentive individuals49,50. Admittedly, as an 
AS might resemble some characteristics of the awake state, it is not identical to it and specific neuronal responses 
can substantial vary when comparing urethane versus awake recordings51. Nevertheless the careful analysis of 
Figure 5. Mean low beta power and corresponding power spectra in the NAC of lean animals measured before 
and after microinjection of either insulin (N = 12) or saline (N = 11) into the third ventricle. Paired t-test was 
used for post-hoc testing to analyze differences in beta activity between conditions, *p < 0.05.
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thesetwo stereotypic cortical activation states - slow wave activity (SWA) and activated state (AS) - secures a high 
level of comparability between recordings in different animals and therefore diminishes interindividual varia-
tions that can lower the sensitivity for the detection of differences between experimental groups. Urethane leaves 
neurotransmission in subcortical areas and in the peripheral nervous system relatively unaffected, which is why 
it is a suitable anesthetic to study basal ganglia function and cortico-basal ganglia interactions52. The electrophys-
iological phenotypes that can be detected under urethane anesthesia have been reproduced in awake recordings 
in numerous cases making the approach a widely used method for preclinical research despite the limitations 
associated with the application of general anesthesia53–55. In this regard, it is important to note that we have found 
no indication of an overall difference in oscillatory brain activity under urethane anesthesia between the groups 
of animals. By comparing the amplitude of low frequency oscillations (0–2 Hz), that signals the depth of the anes-
thesia, we can exclude that this might be an alternative explanation for the observed phenotype. Accordingly, even 
when adjusting for frontal slow wave activity as well as the animal’s body weight and the measurement time the 
highly significant association between baseline insulin levels and baseline NAC beta peak power persisted in a lin-
ear regression model. Another limitation of the present study is that we were not able to quantify cerebral insulin 
levels, which might be of importance to differentiate its effect on beta activity especially against the background 
of the potential relation between transport of insulin into the CSF to peripheral insulin sensitivity56. While beta 
oscillatory activity and coherence clearly differentiate between the two groups our investigation does not allow to 
clarify if obesity itself, high fat diet exposure or insulin resistance are the main drives behind the observed differ-
ent electrophysiological patterns. In summary, the exploration of metabolic processes under a general urethane 
anesthesia comes with a number of limitations but it might offer the specific opportunity to explore an interaction 
between endocrine parameters and default-state network activity. We therefore propose the combined approach 
of endocrinological testing and analysis of default-state oscillatory signaling as novel complementary approach 
to explore neurohumoral interaction.
Conclusion
In the present study, we are the first to identify differential beta oscillatory activity and coherence in the limbic 
cortico-basal ganglia loop in obesity that is strongly correlated with serum insulin and leptin levels. NAC beta 
oscillatory power is enhanced by hyperglycemia and can be induced by direct insulin application into the central 
nervous system. Our data support the hypothesis that obesity and insulin resistance may be considered as circuit 
disorders being characterized by dysfunctional oscillatory network activity in the limbic cortico-basal ganglia 
loop. Future studies should investigate the role of oscillatory brain activity in the pathophysiology of obesity and 
insulin resistance to enable the development of specific neuromodulatory therapies.
Disclosure. Andrea Kühn|Consultancies: Medtronic, St. Jude Medical, Boston Scientific. Advisory Boards: 
Boston Scientific, Medtronic.
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